HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Advanced research in Sclera collagen cross-linking treating progressive myopia].

Abstract
Collagen can link between or within collagen molecules through the covalent bond, which leads to increasing the tension and stability of collagen fiber. Collagen cross-linking had been widely used in other industries, the recent research showed that cross-linking of scleral collagen increased the scleral biomechanical rigidity efficiently, which might become a new treatment modality for strengthening scleral tissue to prevent progressive myopia. This review describes the sclera collagen characteristics of progressive myopia, traditional treatment and sclera collagen cross-linking therapy.
AuthorsYan-yan Zhao, Hong-hong Zhao, Feng-ju Zhang
Journal[Zhonghua yan ke za zhi] Chinese journal of ophthalmology (Zhonghua Yan Ke Za Zhi) Vol. 46 Issue 11 Pg. 1048-51 (Nov 2010) ISSN: 0412-4081 [Print] China
PMID21211301 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cross-Linking Reagents
  • Collagen
Topics
  • Collagen (therapeutic use)
  • Cross-Linking Reagents (therapeutic use)
  • Humans
  • Myopia (drug therapy)
  • Sclera

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: